1. Program Nomination Form: Executive Summary
Name/Department of Principal Investigator:
Target and Therapeutic Indication:
Date of Submission (Month/day/year):
The Right
Information Requested and to be filled in from Principal Investigator (PI), WARF Therapeutics , or Consultant
Target
Tissue
Safety
Patients
Commercial Potential
Molecule (Modality)

2. The Right Target

3. The Right Target (continued)

4. The Right Tissue

5. The Right Tissue (continued)

6. The Right Safety

7. The Right Safety (continued)

8. The Right Patients

9. The Right Patients (continued)

10. The Right Commercial Potential

11. The Right Commercial Potential (continued)